A war of words is simmering between the Chilean government and the pharmaceutical industry over steps the South American country is considering to control rising drug costs.

In recent remarks, Jose Ramon Valente Vias, the minister of Economy, Development, and Tourism, pushed back against the latest effort by the PhRMA industry trade group to convince the U.S. Trade Representative to keep Chile on its annual list of countries that fail to protect and enforce patent rights. The U.S. Trade Rep is due to release its latest so-called U.S. Priority Watch list shortly.

Unlock this article by subscribing to STAT Plus and enjoy your first 30 days free!

GET STARTED

What is it?

STAT Plus is a premium subscription that delivers daily market-moving biopharma coverage and in-depth science reporting from a team with decades of industry experience.

What's included?

  • Authoritative biopharma coverage and analysis, interviews with industry pioneers, policy analysis, and first looks at cutting edge laboratories and early stage research
  • Subscriber-only networking events and panel discussions across the country
  • Monthly subscriber-only live chats with our reporters and experts in the field
  • Discounted tickets to industry events and early-bird access to industry reports

Leave a Comment

Please enter your name.
Please enter a comment.

Sign up for our Daily Recap newsletter

A roundup of STAT’s top stories of the day in science and medicine

Privacy Policy